Evidence map›Paper›PMID 32881260›Full record

ArticleChembiochem : a European journal of chemical biology2021

Probing the Conformation States of Neurotensin Receptor 1 Variants by NMR Site-Directed Methyl Labeling.

Inguna Goba, David Goricanec, Dominik Schum, Matthias Hillenbrand, Andreas Plückthun, Franz Hagn

Open access · hybridAbstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Activation mechanism of the μ-opioid receptor by an allosteric modulator.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Inguna GobaInstitute of Structural Biology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, 85746, Oberschleißheim Neuherberg, Germany.
David GoricanecBavarian NMR Center at the Department of Chemistry, Technical University of Munich, Ernst-Otto-Fischer-Strasse 2, 85747, Garching, Germany.
Dominik SchumBavarian NMR Center at the Department of Chemistry, Technical University of Munich, Ernst-Otto-Fischer-Strasse 2, 85747, Garching, Germany.
Matthias HillenbrandBiochemisches Institut, University of Zürich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.
Andreas PlückthunBiochemisches Institut, University of Zürich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.ORCID 0000-0003-4191-5306
Franz HagnInstitute of Structural Biology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, 85746, Oberschleißheim Neuherberg, Germany.ORCID 0000-0002-1315-459X
Fischer (Germany) · DEUniversity of Zurich · CHHelmholtz Zentrum München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) are key players in mediating signal transduction across the cell membrane. However, due to their intrinsic instability, many GPCRs are not suitable for structural investigations. Various approaches have been developed in recent years to remedy this situation, ranging from the use of more native membrane mimetics to protein-stabilization methods. The latter approach typically results in GPCRs that contain various numbers of mutations. However, probing the functionality of such variants by in vitro and in vivo assays is often time consuming. In addition, to validate the suitability of such GPCRs for structural investigations, an assessment of their conformation state is required. NMR spectroscopy has been proven to be suitable to probe the conformation state of GPCRs in solution. Here, by using chemical labeling with an isotope-labeled methyl probe, we show that the activity and the conformation state of stabilized neurotensin receptor 1 variants obtained from directed evolution can be efficiently assayed in 2D NMR experiments. This strategy enables the quantification of the active and inactive conformation states and the derivation of an estimation of the basal as well as agonist-induced activity of the receptor. Furthermore, this assay can be used as a readout when re-introducing agonist-dependent signaling into a highly stabilized, and thus rigidified, receptor by mutagenesis. This approach will be useful in cases where low production yields do not permit the addition of labeled compounds to the growth medium and where 1D NMR spectra of selectively

Indexed as

Isotope LabelingNuclear Magnetic Resonance, BiomolecularAnimalsModels, MolecularMutationProtein ConformationRatsReceptors, Neurotensinneurotensin type 1 receptorReceptors, NeurotensindynamicsGPCRsmembraneNMR spectroscopysignaling

Identifiers

PMID32881260
PMCPMC7821118
OpenAlexW3082141156

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.